Patient-Reported Outcomes 7 a. Female Sexual Function Index 8 b. Female Sexual Distress Scale-Revised, Item I3 9 c. Other scoring proposals 9 E. Trial Endpoints 9 1. Primary and Key Secondary Endpoints 10 2. Other Secondary Endpoints 11 F. Other Considerations 11 1. Safety Considerations 11 2. Pharma